Methadone replacement therapy: Tried, tested, effective?

Journal of the Royal College of Physicians of Edinburgh

Volumn 42, Issue 2, 2012, Pages 133-136

  Robertson, J R ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Heroin; Injections; Methadone; Narcotics; Opioids; Substance abuse

Indexed keywords

INSULIN; METHADONE; PLACEBO;

ARTICLE; DISEASE ASSOCIATION; DRUG DEPENDENCE; DRUG EFFECT; DRUG EFFICACY; DRUG INFORMATION; DRUG PROGRAM; DRUG RESPONSE; DRUG USE; HEART DISEASE; HEROIN DEPENDENCE; HUMAN; INFECTION; MEDICAL SOCIETY; METHADONE TREATMENT; NEOPLASM; OPIATE ADDICTION; OPIATE SUBSTITUTION TREATMENT; ORGANIZATIONAL DOWNSIZING; ORGANIZATIONAL EFFICIENCY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRESCRIPTION; PROFESSIONAL COMPETENCE; PROFESSIONAL KNOWLEDGE; RISK ASSESSMENT; RISK FACTOR;

EID: 84864230166     PISSN: 14782715     EISSN: None     Source Type: Journal    
DOI: 10.4997/jrcpe.2012.210     Document Type: Article

References (29)

1. Strathdee SA, Hallett TB, Bobrova N et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet 2010; 376:268-84. http://dx.doi.org/10.1016/S0140-6736(10)60743-X
2. Health Protection Scotland, NHS Scotland. An outbreak of anthrax among drug users in Scotland December 2009 to December 2010. A report on behalf of the National Anthrax Outbreak Control Team [Internet]. Glasgow: HPS and NHS Scotland; 2012 [cited 2012 April 4]. Available from: http://www.documents.hps.scot.nhs.uk/ giz/anthrax-outbreak/anthrax-outbreak-report-2011-12.pdf
3. Nelson PK, Mathers BM, Cowie B et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011; 378:571-83. http://dx.doi. org/10.1016/S0140-6736(11)61097-0
4. Hutchinson SJ, Roy KM, Wadd S et al. Hepatitis virus infection in Scotland: epidemiological review and public health challenges. Scott Med J 2006; 51:8-15. http://dx.doi.org/10.1258/rsmsmj.51.2.8
5. Oviedo-Joekes E, Brissette S, Marsh DC et al. Diacetylmorphine versus methadone for the treatment of opioid addiction. N Engl J Med 2009; 361: 777-86. http://dx.doi.org/10.1056/NEJMoa0810635
6. Strang J, Metrebian N, Lintzeris N et al. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial. Lancet 2010; 375:1885-95. http://dx.doi.org/10.1016/S0140-6736(10)60349-2
7. Dole VP, Robinson JW, Orraca J et al. Methadone treatment of randomly selected criminal addicts. N Engl JMed 1969; 280;1372-5. http://dx.doi.org/10.1056/NEJM196906192802502
8. Dole VP, Nyswander M. Rehabilitation of patients on methadone programs. Proceedings of the 5th National Conference on Methadone Treatment. New York: National Association for the Prevention of Addiction; 1973.
9. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services and outcomes. New York: Springer-Verlag; 1991. http://dx.doi.org/10.1007/978-1-4613-9089-3
10. Gossop M, Marsden J, Stewart D et al. The National Treatment Outcome Research Study (NTORS): 4-5 year follow-up results. Addiction 2003; 98:291-303. http://dx.doi.org/10.1046/j.1360-0443.2003.00296.x
11. Gossop M, Stewart D, Browne N et al. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: outcomes at 2-year follow-up. J Subst Abuse Treat 2003; 24:313-21. http://dx.doi.org/10.1016/S0740-5472(03)00040-0
12. Bell J. Delivering effective methadone treatment. In: Ward J, Mattick RP, Hall W, editors. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic Publishers; 1998.
13. National Institute for Health and Clinical Excellence (NICE). Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance 114 [Internet]. London: NICE; 1997 [cited 2012 April 4]. Available from: http:// www.nice.org.uk/guidance/TA114
14. National Institute for Health and Clinical Excellence (NICE). Drug misuse: psychosocial interventions [Internet]. London: NICE; 2007 [cited 2012 April 4]. Available from: http://www.nice.org.uk/CG51
15. Scottish Intercolllegiate College Network (SIGN). Management of hepatitis C. A national clinical guideline [Internet]. Edinburgh: SIGN; 2006 [cited 2012 April 4]. Available from: http://www.sign.ac.uk/ pdf/sign92.pdf
16. Clausen T, Anchersen K, Waal H. Mortality prior to, during and after opioid maintenance treatment (OMT); a national, prospective cross-registry study. Drug Alcohol Depend 2008; 94:151-7. http:// dx.doi.org/10.1016/j.drugalcdep.2007.11.003
17. Davoli M, Bargagli AM, Perucci CA et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction 2007; 102:1954-9. http://dx.doi.org/10.1111/j.1360-0443.2007.02025.x
18. Kimber J, Copeland L, Hickman M et al. Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment. BMJ 2010; 341:c3172. http://dx.doi.org/10.1136/bmj.c3172
19. De Maeyer J, Vanderplasschen W, Camfield L et al. A good quality of life under the influence of methadone: a qualitative study among opiate-dependent individuals. Int J Nurs Stud 2011; 48:1244-57. http://dx.doi.org/10.1016/j.ijnurstu.2011.03.009
20. Mattick RP, Breen C, Kimber J et al. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev 2009; 3:CD002209.
21. Robins LN. The Sixth Thomas James Okey Memorial Lecture. Vietnam veterans' rapid recovery from heroin addiction: a fluke, or normal expectation? Addiction 1993; 88:1041-54. http://dx.doi. org/10.1111/j.1360-0443.1993.tb02123.x
22. Reno RR, Aiken LS. Life activities and life quality of heroin addicts in and out of methadone treatment. Int J Addict 1993; 28:211-32.
23. Robertson JR, Bucknall AB, Welsby PD et al. Epidemic of AIDSrelated virus (HTLV-III/LAV) infection among intravenous drug abusers. Br Med J 1986; 292:527-9. http://dx.doi.org/10.1136/ bmj.292.6519.527
24. Bewley T. Recent changes in the pattern of drug abuse in the United Kingdom. Bull Narcot 1966; 18:1-13.
25. Gunne LM, Grondbladh L. The Swedish methadone maintenance program: a controlled study. Drug Alcohol Depend 1981; 7:249-56. http://dx.doi.org/10.1016/0376-8716(81)90096-X
26. McGlothlin WH, Anglin MD. Long-term follow-up of clients of high-and low-dose methadone programs. Arch Gen Psychiatry 1981; 38:1055-63. http://dx.doi.org/10.1001/archpsyc.1981.01780340107013
27. Department of Health (England) and the devolved administrations. Drug misuse and dependence: UK guidelines on clinical management [Internet]. London: Department of Health (England), the Scottish Government and Northern Ireland Executive; 2007 [cited 2012 April 4]. Available from: http://www.nta.nhs.uk/uploads/clinical_ guidelines_2007.pdf
28. Amato L, Minozzi S, Davoli M et al. Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence. Cochrane Database Syst Rev 2011; 10:CD004147.
29. Scottish Intercollegiate Network (SIGN). Psychosocial intervention in the management of schizophrenia [Internet]. Edinburgh: SIGN; 1998 [cited 2012 April 4]. Available from: http://www.sign.ac.uk/ pdf/sign30.pdf